An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Rheumatoid Arthritis

11/02/2015
15/02/2019
EU PAS number:
EUPAS8571
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

CT-P13 4 2_RA registry protocol_EU-specific_Ver 2.1 03Jun15_Synopsis for PASS_clean

English (31.86 KB - PDF) View document
Study results
Study report
Other information
Study, other information

01 EULAR 2017_CT-P13 4.2 2Y_Abstract (publication only)

English (185.04 KB - PDF) View document